Skip to main content
Fig. 3 | Infectious Agents and Cancer

Fig. 3

From: Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China

Fig. 3

Survival analysis of HBsAg-positive diffuse large B-cell lymphoma patients. A Overall survival (OS) of HBsAg-positive and -negative DLBCL patients. B OS of HBsAg-positive DLBCL patients of more than 60 years old and less than 60 years old. C OS of clinical staging in HBsAg-positive DLBCL patients. D OS of HBsAg-positive DLBCL patients with and without elevated LDH. E OS of HBsAg-positive DLBCL patients with and without spleen involvement. F OS of HBsAg-positive DLBCL patients with and without B symptoms. G OS of HBsAg-positive DLBCL patients with and without coexpression of BCL2 and MYC. H OS of DLBCL patients treated with R-CHOP or CHOP regimens. I OS of HBsAg-positive DLBCL patients treated with R-CHOP or CHOP regimens

Back to article page